Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea
NCT01154244
·
clinicaltrials.gov ↗
COMPLETED
Status
1439
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER:
HOMA-IR
Sponsor
GlaxoSmithKline